Allena Pharmaceuticals Interest Expense 2011-2026 | ALNA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Allena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-38 K	-349 K	-84 K	-13 K	-257 K	-121 K	-7 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-7 K	-349 K	-124 K

Quarterly Interest Expense Allena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	1 K	-7 K	-	-11 K	-32 K	9 K	-	-4 K	-314 K	-7 K	-	-3 K	-16 K	-11 K	-	15 K	-13 K	-7 K	-	-162 K	-34 K	3 K	-	8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
15 K	-314 K	-32.5 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	9.34 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	262 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	23 K	$ 16.88	-2.43 %	$ 789 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Compugen Ltd. CGEN	281 K	$ 2.79	-8.09 %	$ 261 M	Israel
Coherus BioSciences CHRS	9 M	$ 1.6	-2.15 %	$ 187 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Arcturus Therapeutics Holdings ARCT	10.1 M	$ 7.56	-3.45 %	$ 207 M	Israel
Athira Pharma ATHA	1.24 M	-	-	$ 269 M	USA
Galera Therapeutics GRTX	11.4 M	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	3.49 M	$ 3.13	0.32 %	$ 651 M	USA
Exelixis EXEL	-198 K	$ 50.41	-1.36 %	$ 13.7 B	USA
Fortress Biotech FBIO	17.6 M	$ 2.43	5.65 %	$ 67.8 M	USA
Forte Biosciences FBRX	-396 K	$ 23.1	-3.57 %	$ 299 M	USA
Fennec Pharmaceuticals FENC	441 K	$ 9.76	5.63 %	$ 279 M	USA
AbCellera Biologics ABCL	-2.71 M	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	36.7 M	$ 1.59	-	$ 423 M	Britain
BioNTech SE BNTX	14.2 M	$ 89.16	-3.08 %	$ 21.5 B	Germany
Galectin Therapeutics GALT	1.03 M	$ 2.22	-5.74 %	$ 142 M	USA
Gilead Sciences GILD	-1 M	$ 130.07	-1.51 %	$ 162 B	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	561 K	$ 3.41	-2.25 %	$ 5.61 M	Israel
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	1.93 M	$ 0.72	-1.05 %	$ 32.9 M	Israel
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Eton Pharmaceuticals ETON	1.06 M	$ 29.69	-0.92 %	$ 799 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 21.51	-0.3 %	$ 2.74 B	USA